Document ID: chunk:federal_register_of_legislation:F2025C00215:schedule:4:p6
Version: federal_register_of_legislation:F2025C00215
Segment Type: schedule
Provision Reference: sch 4 (pt 6/11)
Character Range: 52515–57157

oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms per dose, 60 doses
Fluticasone propionate                                                       Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms per dose, 60 doses
Fluticasone propionate                                                       Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFC‑free formulation)
Fluticasone propionate                                                       Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFC‑free formulation)
Fluticasone propionate                                                       Pressurised inhalation containing fluticasone propionate 250 micrograms per dose, 120 doses (CFC‑free formulation)
Fluticasone propionate with formoterol                                       Pressurised inhalation containing fluticasone propionate 50 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses
Fluticasone propionate with formoterol                                       Pressurised inhalation containing fluticasone propionate 125 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses
Fluticasone propionate with formoterol                                       Pressurised inhalation containing fluticasone propionate 250 micrograms with formoterol fumarate dihydrate 10 micrograms per dose, 120 doses
Fluticasone propionate with salmeterol                                       Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses
Fluticasone propionate with salmeterol                                       Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses
Fluticasone propionate with salmeterol                                       Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses
Fluticasone propionate with salmeterol                                       Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation)
Fluticasone propionate with salmeterol                                       Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation)
Fluticasone propionate with salmeterol                                       Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation)
Formoterol                                                                   Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 6 micrograms per dose, 60 doses
Formoterol                                                                   Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 12 micrograms per dose, 60 doses
Framycetin                                                                   Eye or ear drops containing framycetin sulfate 5 mg per mL, 8 mL
Furosemide                                                                   Oral solution 10 mg per mL, 30 mL
Glyceryl trinitrate                                                          Sublingual spray (pump pack) 400 micrograms per dose, 200 doses
Goserelin and bicalutamide                                                   Pack containing 1 subcutaneous implant containing goserelin 3.6 mg (as acetate) in pre‑filled injection syringe and 28 tablets bicalutamide 50 mg
Goserelin and bicalutamide                                                   Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre‑filled injection syringe and 28 tablets bicalutamide 50 mg
Goserelin and bicalutamide                                                   Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre‑filled injection syringe and 84 tablets bicalutamide 50 mg
Haloperidol                                                                  Oral solution 2 mg per mL, 100 mL
Hyaluronic acid                                                              Eye drops